✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
圣和化工
首页 › 产品目录 › 特立帕肽

特立帕肽

CAS 52232-67-4C181H291N55O51S2MW 4118

特立帕肽,CAS 登记号 52232-67-4,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号52232-67-4
分子式C181H291N55O51S2
分子量4118
LogP-18.7
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域有机化学品
类别有机化学品

用途与场景

有机化学品

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 特立帕肽 的 CAS 号?

本页已列出 特立帕肽 的 CAS 号:52232-67-4,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

特立帕肽 一般用在什么产品里?

主要涉及有机化学品。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

Teriparatide · CAS 52232-67-4 · C181H291N55O51S2. UNII 10T9CSU89I.

Identification

CAS Registry Number52232-67-4
PubChem CID16133850
Molecular formulaC181H291N55O51S2
UNII (FDA)10T9CSU89I

Computed Descriptors

Molecular Weight4118
XLogP3-18.7
Hydrogen Bond Donor Count60
Hydrogen Bond Acceptor Count62
Rotatable Bond Count146
Exact Mass4116.1342973
Monoisotopic Mass4115.1309424
Topological Polar Surface Area1800
Heavy Atom Count289
Formal Charge0

Physical description & handling notes

  • Parenteral: Injection: 750 ug/3 mL (20 ug per metered dose/pen device), Forteo (available as prefilled disposable cartridge), (Lilly).

GHS Hazard Classification

Reported hazard statementsH302 (16.7%), H332 (16.7%), H351 (50%), H361 (100%), H372 (33.3%), H373 (16.7%), H336, H350

H302 (16.7%): Harmful if swallowed [Warning Acute toxicity, oral]

H332 (16.7%): Harmful if inhaled [Warning Acute toxicity, inhalation]

Documented Uses

  • Stimulates new bone formation on trabecular and cortical (periosteal and/or endosteal) bone surfaces by preferential stimulation of osteoblastic activity over osteoclastic activity.
  • Bone Density Conservation Agents
  • Manufactured using a strain of Escherichia coli modified by recombinant DNA technology
  • Teriparatide is a recombinant human parathyroid hormone analogue that is used to treat osteoporosis in women or men with a high risk for bone fracture. Teriparatide therapy has not been associated with serum aminotransferase elevations during therapy and has not been implicated in instances of clinically apparent liver injury.
  • Breast Feeding; Lactation; Milk, Human; Parathyroid Hormone; Calcium-Regulating Hormones and Agents; Bone Density Conservation Agents
  • Teriparatide (genetical recombination)

Synonyms

TERIPARATIDE; 52232-67-4; Teriparatida; Teriparatidum; 1-34-Human PTH; Human PTH (1-34); ZT-034; LY 333334; 10T9CSU89I; TERIPARATIDE RECOMBINANT HUMAN; hPTH (1-34); BONSITY; RefChem:56774; H05AA02; DTXSID001027900; Teriparatide (genetical recombination)

Frequently Asked Questions

What are the CAS number and molecular formula of Teriparatide?

CAS 52232-67-4; molecular formula C181H291N55O51S2; molecular weight — g/mol.

What other names is Teriparatide known by?

TERIPARATIDE, 52232-67-4, Teriparatida, Teriparatidum, 1-34-Human PTH, Human PTH (1-34).

Is Teriparatide classified as hazardous?

Hazard statements reported: H302, H332, H351, H361, H372.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 特立帕肽 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1